aliquot_line

TL3 Regular · Valladolid, ES

Wiki editor. Small, frequent, well-annotated edits.

Joined 13 October 2024 · last posted 7h · groups: wiki-editors

134 posts, newest first. Showing up to 150.

Compounds this community declines to help with, and why — does this still hold? Replied, post #8 · Compounds › Other compounds · 28 Jul 2026 · 8 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
Coming back to: When a red flag was a misunderstanding, and the retraction Replied, post #11 · Sourcing › Red flags · 27 Jul 2026 · 22 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Retatrutide mass and identity: what a report should show Replied, post #28 · Compounds › Retatrutide · 27 Jul 2026 · 18 likes I had written a reply contradicting post #25 and deleted it. Here is what survived. Agreed on retatrutide mass and identity, with one qualification that I think…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #50 · Practice › Interactions · 21 Jul 2026 · 13 likes Checked the Delayed gastric emptying and oral claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #98 · Practice › Administration · 19 Jul 2026 · 14 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Here for the analytics and not much else Replied, post #49 · Lounge › Introductions · 17 Jul 2026 · 14 likes Welcome. If you have an analytical background you will find the analytics subcategories the easiest place to be useful quickly — the recurring gap here is people who…
Pooling trials with different estimands Replied, post #101 · Evidence › Meta-analyses · 16 Jul 2026 · 2 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Which categories are strict and which are relaxed, honestly Replied, post #15 · Start Here › Welcome · 14 Jul 2026 · 2 likes Nobody is going to check your credentials and nobody is going to ask. What gets asked for is the basis of a claim, which is a different thing and applies equally to…
Selection into a registry and what it does to the estimate — a second dataset Replied, post #16 · Evidence › Study critique · 13 Jul 2026 · 28 likes Post #14 is right about the mechanism and I think understates the practical bit. Generalisability and validity are separate axes. A trial can be internally impeccable…
Why this subcategory is stricter about sourcing than most Replied, post #50 · Compounds › Secretagogues & GH axis · 1 Jul 2026 · 8 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
Electrolyte supplements: which ones do anything Replied, post #43 · Nutrition & Training › Hydration & electrolytes · 30 Jun 2026 · 6 likes Post #42 is the version of this I will quote in future. One addition. Electrolyte supplements looks different depending on whether you are reading the primary…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #56 · Analytics › HPLC & UHPLC · 21 Jun 2026 · 13 likes The number people quote for Carryover is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on…
Journal club: what we got wrong in an earlier session Replied, post #17 · Evidence › Journal club · 20 Jun 2026 · 2 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
Transporting a vial for a weekend away — a second dataset Replied, post #85 · Practice › Storage & stability · 17 Jun 2026 · 5 likes Noted, and I have changed what I was going to do on the strength of it.
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #24 · Documentation › Doc review · 16 Jun 2026 · 2 likes On post #21 — agreed on the reasoning, with one qualification. A review date is a commitment rather than a formality, and a shorter cycle for a fast-moving subject is…
What I would want from a home test that does not exist yet — what changed since Replied, post #55 · Analytics › Home & field testing · 15 Jun 2026 · 0 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide.…
Journal club: what we got wrong in an earlier session Replied, post #3 · Evidence › Journal club · 13 Jun 2026 · 32 likes Building on post #2 rather than restating it. The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells…
Insurance and replacement policies, compared Replied, post #16 · Sourcing › Logistics · 12 Jun 2026 · 6 likes Adding the measurement that post #14 says would settle it. Peak periods and public holidays affect this more than any other factor and are entirely predictable in…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #73 · Practice › Administration · 4 Jun 2026 · 25 likes Checked the Rotating between abdomen claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
What steady state means for the decision to escalate Replied, post #8 · Practice › Dosing & titration · 1 Jun 2026 · 28 likes Where I part company with post #6, and it is a narrow parting. The question underneath steady state is usually "how would I tell?" rather than "what is true?", and that…
Search filters: what is missing Replied, post #64 · Meta › Site feedback · 1 Jun 2026 · 5 likes Post #63 is right about the mechanism and I think understates the practical bit. Trying to state the search filters position in a way that someone who disagrees would…
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #33 · Practice › Storage & stability · 31 May 2026 · 26 likes Source for the Mean kinetic temperature figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #54 · Sourcing › Red flags · 29 May 2026 · 13 likes I had written a reply contradicting post #50 and deleted it. Here is what survived. The thing about supplier that took me longest to accept is that a plausible…
What a good consultation looks like from the other side Replied, post #44 · Clinical › Prescriber conversations · 27 May 2026 · 1 like Post #42 describes the usual case. This is about the unusual one. Good consultation is a question about a distribution, not about a value, and treating it as a value is…
The best-written scientific paper you have read Replied, post #54 · Lounge › Off topic · 19 May 2026 · 2 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
Tracking a shortage from primary sources rather than rumour Replied, post #12 · Access › Shortages · 17 May 2026 · 21 likes Everything in post #10 holds. The case it does not cover is the one I have. Where an alternative within the class is available, the comparison is a clinical one and the…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #48 · Compounds › Tirzepatide · 13 May 2026 · 11 likes Building on post #47 rather than restating it. Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone…
[2026 update] What a good consultation looks like from the other side Replied, post #31 · Clinical › Prescriber conversations · 13 May 2026 · 1 like Written summaries after an appointment are available in many systems and are worth asking for, because recollection of a consultation is unreliable. On balance I think…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #37 · Analytics › COA interpretation · 8 May 2026 · 25 likes Reused chromatograms across lots is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly.…
Request: show the solution author in the topic list — what changed since Replied, post #70 · Meta › Feature requests · 3 May 2026 · 0 likes Request from the analytics side: allow a table in a post to be marked as data rather than layout, so it can be copied without the formatting. Half the tables here are…
Prescription requirements and telehealth models — a second dataset Replied, post #15 · Sourcing › Regulatory · 29 Apr 2026 · 5 likes Where I part company with post #11, and it is a narrow parting. If you can confirm or contradict a position for your own region, please date the answer. An undated…
Personal import allowances, compared — a second dataset Replied, post #113 · Access › International · 29 Apr 2026 · 27 likes The thing about Personal import allowances that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #52 · Data & Tools › Datasets · 16 Apr 2026 · 0 likes Checked the community side-effect dataset claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #5 · Practice › Reconstitution · 15 Apr 2026 · 8 likes I would call the community position on Reconstituting a multi-strength kit likely rather than established, and I would be comfortable defending that hedge.
Foaming during reconstitution and whether it matters — the long version Replied, post #98 · Practice › Reconstitution · 14 Apr 2026 · 2 likes Adding a null result on Foaming during reconstitution. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Sample handling between despatch and injection Replied, post #32 · Analytics › Method validation · 11 Apr 2026 · 26 likes A note on how sample handling between despatch gets discussed rather than on sample handling between despatch itself: the confident posts get the replies and the…
Chain of custody for a sample you posted yourself — one year on Replied, post #12 · Sourcing › Independent verification · 8 Apr 2026 · 16 likes What I can speak to on Chain of custody is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Follow-up: State-level differences that actually matter Replied, post #64 · Regional › North America · 7 Apr 2026 · 0 likes Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so on their own account. I would treat the number as indicative rather than…
Follow-up: State-level differences that actually matter Replied, post #11 · Regional › North America · 4 Apr 2026 · 30 likes That is the distinction I keep failing to hold on to. Written down now.
An ABAB design with a data table and honest limitations — a second dataset Replied, post #45 · Research Methods › N-of-1 designs · 8 Mar 2026 · 10 likes Confirming post #43 from a second method, which matters more than confirming it from a second person. Careful with the language on ABAB design. "Not detected" and "not…
Follow-up: Request: a per-category review queue Started this topic · Meta › Feature requests · 7 Mar 2026 · 8 likes On the subject in the title: Request: a per-category review queue Working notes rather than a conclusion. A follow-up question about per-category review queue that I…
Preprint servers and what screening they do Replied, post #73 · Evidence › Preprints · 1 Mar 2026 · 1 like Post #71 is the version of this I will quote in future. One addition. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint].…
The lowest dose that does anything: is that a real question? Replied, post #8 · Practice › Dosing & titration · 1 Mar 2026 · 3 likes Post #4 and I disagree about the size of the effect, not about the direction. Steady state means the plasma concentration is stable from dose to dose. That happens…
Conditions that change the calculus rather than forbidding it Started this topic · Safety › Contraindications · 23 Feb 2026 · 0 likes Conditions that change the calculus rather than forbidding it Writing it up because I had to work it out twice and would rather nobody else did. What changes if the…
Request: export my own posts — one year on Replied, post #50 · Meta › Feature requests · 22 Feb 2026 · 4 likes Seconded, and it is also the honest complement to an archive that keeps your posts after you close your account.
Request declined, with reasoning — what changed since Replied, post #14 · Meta › Feature requests · 19 Feb 2026 · 29 likes Post #13 is right about the mechanism and I think understates the practical bit. Request from the analytics side: allow a table in a post to be marked as data rather…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #52 · Clinical › Bloodwork · 18 Feb 2026 · 0 likes Two people in this thread mean different things by reference intervals and are disagreeing about the definition while believing they are disagreeing about the facts.…
Mass error in ppm: the arithmetic and the caveat Replied, post #79 · Analytics › Mass spectrometry · 14 Feb 2026 · 0 likes For a compound with no reference standard in circulation, an observed mass is much more useful than an assertion of agreement with a theoretical value nobody can check.
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #42 · Pharmacology › Pharmacokinetics · 14 Feb 2026 · 0 likes Answering the question post #38 raises rather than the one it answers. Genuine question rather than a rhetorical one: has anyone here actually observed Washout, as…
Trifluoroacetate content and its consequences Replied, post #127 · Analytics › Impurities & related substances · 11 Feb 2026 · 32 likes My understanding of trifluoroacetate content is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating…
Preprint servers and what screening they do Replied, post #42 · Evidence › Preprints · 1 Feb 2026 · 11 likes Where the preprint servers reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
[2026 update] What a purity-only report leaves out Replied, post #7 · Sourcing › Independent verification · 23 Jan 2026 · 8 likes Coming back to post #3, because the follow-up matters more than the original answer. Repeat determination on the same product line months apart is the measurement that…
Interpreting a result that disagrees with the supplier's certificate Replied, post #75 · Sourcing › Independent verification · 10 Jan 2026 · 6 likes A note on scope: what I am saying about interpreting a result applies to the case in the first post and I would not extend it further without checking.
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #48 · Pharmacology › Receptor biology · 8 Jan 2026 · 0 likes Receptor occupancy required for a clinical effect is not the same as full occupancy, and dose-response curves flattening at the top is what you would expect from that.
Heterogeneity as information rather than as a nuisance Replied, post #52 · Evidence › Meta-analyses · 6 Jan 2026 · 23 likes I have three months of notes on heterogeneity and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #25 · Compounds › Retatrutide · 22 Dec 2025 · 4 likes Post #24 is right about the mechanism and I think understates the practical bit. The evidence status here should be stated in the first line of any post about it rather…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #17 · Pharmacology › Receptor biology · 18 Dec 2025 · 0 likes Receptor occupancy required for a clinical effect is not the same as full occupancy, and dose-response curves flattening at the top is what you would expect from that.
Batch date after test date, and other internal inconsistencies Replied, post #26 · Analytics › COA interpretation · 12 Dec 2025 · 19 likes Thank you for the correction. I would rather find out here than later.
Documentation that materially improves an appeal's chances Replied, post #90 · Access › Insurance & coverage · 5 Dec 2025 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
[2026 update] Long-time reader, first-time poster Replied, post #30 · Lounge › Introductions · 3 Dec 2025 · 1 like Two questions I would want answered before drawing anything from the Long-time reader data above: how were the cases selected, and what happened to the ones that…
What pooling buys you and what it destroys Replied, post #82 · Evidence › Meta-analyses · 3 Dec 2025 · 26 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #99 · Documentation › Doc review · 24 Nov 2025 · 4 likes The arithmetic on Promotion criteria is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Pen dose counters: what a click does and does not guarantee Replied, post #56 · Devices › Pens & autoinjectors · 16 Nov 2025 · 2 likes Post #55 is the version of this I will quote in future. One addition. Storage after first use: most pens can be stored at room temperature after first use, even if…
MHRA statements, read directly Replied, post #31 · Regional › UK & Ireland · 14 Nov 2025 · 29 likes Since MHRA statements keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
Personal import allowances, compared — a second dataset Replied, post #18 · Access › International · 5 Nov 2025 · 1 like Post #14 and I disagree about the size of the effect, not about the direction. Where a compound is approved under a different trade name in another market, searching…
Publishing an inconvenient result: a case study — the long version Replied, post #27 · Sourcing › Independent verification · 4 Nov 2025 · 0 likes Post #25 and I disagree about the size of the effect, not about the direction. Two sentences on Publishing an inconvenient result and then I will stop, because the rest…
Reading SURMOUNT-1 without the press release — one year on Replied, post #19 · Compounds › Tirzepatide · 3 Nov 2025 · 7 likes That is clearer than the version I had in my head. Thank you.
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #4 · Compounds › Semaglutide · 18 Oct 2025 · 10 likes Everything in the opening post holds. The case it does not cover is the one I have. On dose steps: the four-week interval in the pivotal programme was a trial design…
A parcel that arrived warm: a decision process, not a verdict Replied, post #88 · Practice › Storage & stability · 17 Oct 2025 · 3 likes Understood, and I withdraw the assumption I opened with.
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #24 · Compounds › Semaglutide · 10 Oct 2025 · 6 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #25 · Analytics › HPLC & UHPLC · 8 Oct 2025 · 13 likes Post #24 is the version of this I will quote in future. One addition. Counterpoint on integrator, offered without confidence: the same observation is consistent with a…
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #7 · Compounds › Tirzepatide · 26 Sep 2025 · 14 likes Taking post #6 at face value and following it one step further. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading…
Moderation log format change Started this topic · Meta › Announcements · 25 Sep 2025 · 16 likes Posting this under the heading it deserves: Moderation log format change Everything below is what sits behind that. Moderation log format change keeps being re-asked…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #42 · Compounds › Other compounds · 12 Sep 2025 · 18 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #53 · Practice › Side effects · 11 Sep 2025 · 0 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #10 · Data & Tools › Datasets · 6 Sep 2025 · 15 likes Post #7 is right about the mechanism and I think understates the practical bit. On Aggregated purity results across four, I would rather understate and be corrected…
Theoretical plates: useful number or ritual? Replied, post #2 · Analytics › HPLC & UHPLC · 4 Sep 2025 · 6 likes Change the wavelength and the proportions change even though the sample has not. That is the reason the wavelength has to be on the document for the number to mean…
High-resolution MS on aggregates and what it can see Replied, post #59 · Analytics › Mass spectrometry · 3 Sep 2025 · 20 likes Answering the question post #57 raises rather than the one it answers. Small methodological point on high-resolution: repeating a measurement is cheap and resolves most…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #16 · Data & Tools › Datasets · 1 Sep 2025 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
Tag proliferation and whether we should prune Started this topic · Meta › Site feedback · 1 Sep 2025 · 37 likes On the subject in the title: Tag proliferation and whether we should prune Working notes rather than a conclusion. I have spent a fortnight trying to pin tag…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #113 · Compounds › Repair & healing peptides · 24 Aug 2025 · 7 likes I keep a log for TB-500 and thymosin beta-4 specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #61 · Clinical › Special populations · 16 Aug 2025 · 0 likes Post #58 is right about the mechanism and I think understates the practical bit. Genetic and ancestry-related differences in response are asked about regularly and the…
A request that was declined, and the reasoning — a second dataset Replied, post #83 · Documentation › Wiki requests · 14 Aug 2025 · 0 likes Post #79 and I disagree about the size of the effect, not about the direction. Accessibility feedback: if you have trouble accessing or reading a maintained page…
Thyroid function tests during substantial weight change Replied, post #21 · Clinical › Bloodwork · 4 Aug 2025 · 12 likes Lipid changes during substantial weight loss are expected and their trajectory is not always monotonic. A single mid-course panel can be misleading. That has held every…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #101 · Wellbeing › Mental health · 31 Jul 2025 · 0 likes On post #99 — agreed on the reasoning, with one qualification. Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the…
Follow-up: Why appetite effects are mostly central Replied, post #7 · Pharmacology › Receptor biology · 28 Jul 2025 · 0 likes Narrowing post #6, because the general version has more than one answer. Half-life extension by albumin binding through a fatty acid chain trades free fraction for…
Sequence verification for an obscure compound: how it is done Replied, post #106 · Compounds › Other compounds · 27 Jul 2025 · 31 likes Post #102 describes the usual case. This is about the unusual one. I keep a log for sequence verification specifically because my memory of it turned out to be…
Canadian access and provincial variation — one year on Replied, post #31 · Regional › North America · 26 Jul 2025 · 8 likes Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction.
Which panel is worth repeating and which is worth ignoring Replied, post #55 · Clinical › Bloodwork · 7 Jul 2025 · 27 likes The strongest argument against my own position on panel, stated as well as I can state it, since nobody else has yet.
Sodium, potassium and magnesium when intake drops Replied, post #46 · Nutrition & Training › Hydration & electrolytes · 6 Jul 2025 · 20 likes Baseline measurements before a substantial change in intake give you something to compare against, and almost nobody has them.
Discussing something you have already been doing — the long version Replied, post #3 · Clinical › Prescriber conversations · 4 Jul 2025 · 6 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. A question phrased as "what would you want to see before considering X" is…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #64 · Pharmacology › Pharmacokinetics · 25 Jun 2025 · 25 likes I had written a reply contradicting post #62 and deleted it. Here is what survived. Reading back through the Clearance pathways threads from last year, the same three…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #51 · Pharmacology › Pharmacokinetics · 18 Jun 2025 · 13 likes On post #48 — agreed on the reasoning, with one qualification. I think the Clearance pathways question is answerable and has not been answered, which is a more…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #56 · Evidence › Journal club · 13 Jun 2025 · 3 likes The arithmetic in post #55 is right; the assumption feeding it is the part to check. The practical version of STEP 4 is three sentences long. The rigorous version is…
Reverting an edit that had no revision note Replied, post #9 · Meta › Wiki maintenance · 8 Jun 2025 · 1 like The practical version of reverting an edit is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
Sequence verification for an obscure compound: how it is done Replied, post #49 · Compounds › Other compounds · 31 May 2025 · 5 likes Noted, and I have changed what I was going to do on the strength of it.
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #41 · Evidence › Trials · 30 May 2025 · 32 likes Where the Comparators chosen for regulatory reasons discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies".…
Which panel is worth repeating and which is worth ignoring Replied, post #28 · Clinical › Bloodwork · 30 May 2025 · 27 likes Picking up post #27: that is the part I would want checked first. A trend needs at least three points to be a trend. Two points are a line and a line through noise is…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #56 · Compounds › Other compounds · 20 May 2025 · 21 likes Research use only, not approved for human use, and in this subcategory the compounds vary enormously in how much is known about them. It is worth establishing which end…
Reading a trial's population section before its results — does this still hold? Replied, post #118 · Evidence › Trials · 18 May 2025 · 1 like Adding the measurement that post #117 says would settle it. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index…
Why the timeline is on the right and not the left Replied, post #18 · Meta › Site feedback · 16 May 2025 · 16 likes My experience of timeline contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
A claim built entirely on a subgroup analysis Replied, post #36 · Evidence › Study critique · 15 May 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
Shakes versus food: a pragmatic assessment — the long version Replied, post #25 · Nutrition & Training › Protein & intake · 15 May 2025 · 7 likes Small methodological point on Shakes versus food: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
About the Repair & healing peptides category Replied, post #4 · Compounds › Repair & healing peptides · 12 May 2025 · 7 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #6 · Compounds › Repair & healing peptides · 2 May 2025 · 22 likes Narrowing post #4, because the general version has more than one answer. Two questions I would want answered before drawing anything from the TB-500 and thymosin beta-4…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #21 · Sourcing › Independent verification · 27 Apr 2025 · 27 likes Worth separating two things that post #18 runs together. A record with four results over sixteen months is a thin record rather than a bad one, and the honest…
Coverage for the indication versus for the drug Replied, post #44 · Access › Insurance & coverage · 27 Apr 2025 · 7 likes The arithmetic in post #43 is right; the assumption feeding it is the part to check. I would call the community position on coverage likely rather than established, and…
Shakes versus food: a pragmatic assessment — the long version Replied, post #7 · Nutrition & Training › Protein & intake · 23 Apr 2025 · 15 likes Building on post #6 rather than restating it. Where the Shakes versus food reasoning breaks down for me is the step from the group result to the individual case. That…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #135 · Sourcing › Regulatory · 23 Apr 2025 · 12 likes That is a cleaner way of putting what I was circling around.
When "no data" is the complete and final answer Replied, post #147 · Compounds › Other compounds · 13 Apr 2025 · 33 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #74 · Practice › Reconstitution · 8 Apr 2025 · 9 likes Taking 5 mg vial seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
Retatrutide dose escalation in the published trials Replied, post #55 · Compounds › Retatrutide · 27 Mar 2025 · 1 like On analysis: a chromatographic purity figure for an investigational compound is harder to interpret than for a well-characterised one, because there is no reference…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #87 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Where I part company with post #85, and it is a narrow parting. The format we ask for is compound, lot, testing service, method as reported, result, and the certificate…
When "no data" is the complete and final answer Replied, post #118 · Compounds › Other compounds · 14 Mar 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
Validating a method you did not develop — does this still hold? Replied, post #37 · Analytics › Method validation · 23 Feb 2025 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
What we do not know about retatrutide, listed explicitly Replied, post #97 · Compounds › Retatrutide · 15 Feb 2025 · 28 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #120 · Evidence › Journal club · 8 Feb 2025 · 7 likes Confirming post #117 from a second method, which matters more than confirming it from a second person. Where the SURPASS-2 reasoning breaks down for me is the step from…
Protein density versus volume when you cannot eat much Replied, post #89 · Nutrition & Training › Protein & intake · 8 Feb 2025 · 1 like Narrowing post #86, because the general version has more than one answer. Worth stating the null on protein density versus volume before we explain it: the observation…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #79 · Data & Tools › Calculators · 6 Feb 2025 · 19 likes A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which step you disagree with.
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #17 · Access › International · 28 Jan 2025 · 2 likes Post #13 describes the usual case. This is about the unusual one. Summarising the Cross-border purchase within thread so far, since it is long and the answer is buried:…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #7 · Analytics › COA interpretation · 15 Jan 2025 · 0 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #63 · Compounds › Semaglutide · 22 Dec 2024 · 7 likes Useful. I had the fact and not the reason, which turns out to be the important half.
A page that has drifted out of date and needs a maintainer Replied, post #40 · Documentation › Wiki requests · 16 Dec 2024 · 17 likes Second this, and I would have said it less carefully.
Coming back to: Renal impairment: what the labelling says about dose Replied, post #20 · Clinical › Special populations · 7 Dec 2024 · 0 likes Two questions I would want answered before drawing anything from the Renal impairment data above: how were the cases selected, and what happened to the ones that…
EMA product information as a primary source — does this still hold? Replied, post #132 · Regional › European Union · 18 Nov 2024 · 11 likes My experience of EMA product information contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
The topic list is dense — is that deliberate? Replied, post #53 · Meta › Site feedback · 16 Nov 2024 · 0 likes Answering the topic list question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first…
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #30 · Sourcing › Independent verification · 13 Nov 2024 · 2 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #15 · Compounds › Semaglutide · 7 Nov 2024 · 15 likes Gallbladder events appear in the labelling for this class and are more common with larger, faster weight reduction. The mechanism is not specific to the drug — rapid…
Blind submission and why it changes minds Replied, post #82 · Sourcing › Independent verification · 8 Oct 2024 · 0 likes That reframing is the whole thing. The facts I already had.
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #65 · Sourcing › Independent verification · 17 Sep 2024 · 0 likes Splitting a vial is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
A rising related-substance total over six months: degradation or method drift? Replied, post #8 · Analytics › Impurities & related substances · 25 Aug 2024 · 26 likes Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable only on a method chosen for the purpose. Standard reversed-phase…
Follow-up: Dead volume across syringe and needle combinations Replied, post #16 · Devices › Syringes & needles · 2 Aug 2024 · 6 likes Drawing through a wider needle and injecting through a thinner one is a reasonable approach for a viscous preparation and pointless for an aqueous one. The claim is…
The mass-error checker and its intended scope Replied, post #123 · Data & Tools › Calculators · 14 Jul 2024 · 29 likes Post #122 is right about the mechanism and I think understates the practical bit. Significant figures in the output should not exceed what the inputs support. A…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #33 · Practice › Dosing & titration · 7 Jul 2024 · 17 likes I had written a reply contradicting post #31 and deleted it. Here is what survived. The confident answers on Splitting a weekly dose and the well-sourced answers are…